KESTRA MEDICAL TECHNOLOGIES, LTD.
For the period ended Apr 30, 2026. Filed Jul 14, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jul 14, 2026
KMTS$30.12+4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| April 30, | April 30, | |
|---|---|---|
| 2026 | 2025 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $99,710 | $237,595 |
| Short-term investments | 96,724 | — |
| Accounts receivable, net | 14,542 | 8,081 |
| Disposable medical equipment supplies | 6,706 | 6,572 |
| Prepaid expenses and other current assets | 4,677 | 3,080 |
| Total current assets | 222,359 | 255,328 |
| Long-term investments | 65,767 | — |
| Right-of-use assets | 3,364 | 2,078 |
| Deposits | 1,761 | 2,021 |
| Restricted cash | 334 | 334 |
| Property and equipment, net | 59,090 | 34,830 |
| Other long-term assets | 5,790 | 1,153 |
| Total assets | $358,465 | $295,744 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $27,295 | $23,961 |
| Accrued liabilities | 23,046 | 13,829 |
| Operating lease liabilities, current portion | 31 | 187 |
| Total current liabilities | 50,372 | 37,977 |
| Operating lease liabilities, net of current portion | 4,111 | 3,026 |
| Warrant liabilities | 1,369 | 8,097 |
| Other long-term liabilities | 306 | 140 |
| Long-term debt, net | 42,649 | 41,098 |
| Total liabilities | 98,807 | 90,338 |
| Commitments and contingencies (Note 14) | ||
| Shareholders’ equity | ||
| Common Shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2026 and April 30, 2025; 58,383,924 issued and outstanding as of April 30, 2026 and 51,348,656 shares issued and outstanding as of April 30, 2025 | 58,384 | 51,349 |
| Additional paid-in capital | 853,353 | 674,306 |
| Accumulated other comprehensive loss | (218) | — |
| Accumulated deficit | (651,861) | (520,249) |
| Total shareholders’ equity | 259,658 | 205,406 |
| Total liabilities and shareholders’ equity | $358,465 | $295,744 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.